Evidence map›Paper›PMID 28920929›Full record

ArticleOncogenesis2017

Structural investigation of nucleophosmin interaction with the tumor suppressor Fbw7γ.

A Di Matteo, M Franceschini, A Paiardini, A Grottesi, S Chiarella, S Rocchio, C Di Natale, D Marasco, L Vitagliano, C Travaglini-Allocatelli and 1 more

Open access · goldAbstract read
In one paragraph

Article in Oncogenesis, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 19 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Insights into Network of Hot Spots of Aggregation in Nucleophosmin 1.International journal of molecular sciences · 2022
    Article
  6. Article
  7. Nucleophosmin in Its Interaction with Ligands.International journal of molecular sciences · 2020
    Review
  8. Article
  9. The Dundee Resource for Sequence Analysis and Structure Prediction.Protein science : a publication of the Protein Society · 2020
    Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 1 country.

A Di MatteoIstituto di Biologia e Patologia Molecolari - Consiglio Nazionale delle ricerche, Roma, Italy.
M FranceschiniDipartimento di Scienze Mediche, Orali e Biotecnologiche, Chieti, Italy.
A PaiardiniDipartimento di Biologia e Biotecnologie 'C Darwin' - Sapienza Università di Roma, Roma, Italy.
A GrottesiCINECA Consorzio Interuniversitario, Sede di Roma, Roma, Italy.
S ChiarellaDipartimento di Scienze Mediche, Orali e Biotecnologiche, Chieti, Italy.
S RocchioDipartimento di Scienze Biochimiche 'A Rossi Fanelli' - Sapienza Università di Roma, Roma, Italy.
C Di NataleDipartimento di Farmacia,- Università di Napoli 'Federico II', Napoli, Italy.
D MarascoDipartimento di Farmacia,- Università di Napoli 'Federico II', Napoli, Italy.
L VitaglianoIstituto di Biostrutture e Bioimmagini - Consiglio Nazionale delle Ricerche, Napoli, Italy.
C Travaglini-AllocatelliDipartimento di Scienze Biochimiche 'A Rossi Fanelli' - Sapienza Università di Roma, Roma, Italy.
L FedericiDipartimento di Scienze Mediche, Orali e Biotecnologiche, Chieti, Italy.
Sapienza University of Rome · ITUniversity of Chieti-Pescara · ITUniversity of Naples Federico II · ITInstitute of Biostructure and Bioimaging · ITInstitute of Molecular Biology and Pathology · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nucleophosmin (NPM1) is a multifunctional nucleolar protein implicated in ribogenesis, centrosome duplication, cell cycle control, regulation of DNA repair and apoptotic response to stress stimuli. The majority of these functions are played through the interactions with a variety of protein partners. NPM1 is frequently overexpressed in solid tumors of different histological origin. Furthermore NPM1 is the most frequently mutated protein in acute myeloid leukemia (AML) patients. Mutations map to the C-terminal domain and lead to the aberrant and stable localization of the protein in the cytoplasm of leukemic blasts. Among NPM1 protein partners, a pivotal role is played by the tumor suppressor Fbw7γ, an E3-ubiquitin ligase that degrades oncoproteins like c-MYC, cyclin E, Notch and c-jun. In AML with NPM1 mutations, Fbw7γ is degraded following its abnormal cytosolic delocalization by mutated NPM1. This mechanism also applies to other tumor suppressors and it has been suggested that it may play a key role in leukemogenesis. Here we analyse the interaction between NPM1 and Fbw7γ, by identifying the protein surfaces implicated in recognition and key aminoacids involved. Based on the results of computational methods, we propose a structural model for the interaction, which is substantiated by experimental findings on several site-directed mutants. We also extend the analysis to two other NPM1 partners (HIV Tat and CENP-W) and conclude that NPM1 uses the same molecular surface as a platform for recognizing different protein partners. We suggest that this region of NPM1 may be targeted for cancer treatment.

Identifiers

PMID28920929
PMCPMC5623904
OpenAlexW2755659389

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.